)
)
Otonomy Investor Relations Material
Latest events
Q2 2022
Otonomy
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Otonomy Inc
Access all reports
Otonomy Inc. is a biopharmaceutical company focused on the development of therapeutics for the treatment of ear-related disorders. The company leverages proprietary drug delivery technology to create sustained-exposure formulations designed for conditions such as hearing loss, tinnitus, and otitis media. Otonomy’s pipeline includes both investigational therapies and products aimed at addressing unmet medical needs in otology. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
OTIC
Country
🇺🇸 United States